ACRO Biomedical Co., Ltd. (TPEX:6748)
58.70
-2.60 (-4.24%)
Mar 9, 2026, 1:45 PM CST
ACRO Biomedical Revenue
ACRO Biomedical had revenue of 13.32M TWD in the half year ending June 30, 2025, a decrease of -15.74%. This brings the company's revenue in the last twelve months to 36.50M, down -35.18% year-over-year. In the year 2024, ACRO Biomedical had annual revenue of 44.23M, down -13.38%.
Revenue (ttm)
36.50M
Revenue Growth
-35.18%
P/S Ratio
104.15
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.80B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Genovate Biotechnology | 492.41M |
| Sagittarius Life Science | 424.44M |
| Formosa Pharmaceuticals | 12.16M |
| BRIM Biotechnology | 3.17M |
| Intech Biopharm | 113.85M |
| Energenesis Biomedical CO.,LTD. | 7.46M |
| Medigen Biotechnology | 1.59B |
| SYN-TECH Chem. & Pharm. | 1.30B |